295. The Neuroscience of Antidepressants Pt 1. Drugs based around the monoamine hypothesis

There’s a lot of talk about the monoamine hypothesis of Depression, which is the theory that a reduced level of serotonin, dopamine and norepinephrine in the central nervous system is what causes symptoms of depression, but is it the cause? In this episode we’ll find out what the evidence is, and what treatments work based on that hypothesis, and how they relate to the drugs that are currently on the market to treat symptoms of Depression. In the next episode we'll go into more detail about the glutamatergic system and how these drugs interact with the brain, and potentially new treatments that could potentially reverse the negative side effects of some of the existing treatments. LINKS: Listen to Part 2 of the Neuroscience of Antidepressants: The Glutamate Hypothesis at https://pod.fo/e/219f62 .  Listen to my episode on Ketamine as a treatment for depression here https://bit.ly/Dyfm-ketamine. Join the DYFM Facebook Group https://bit.ly/dyfm-group . Follow @dyfmpodcast on IG  Follow @alexispredez on IG   Follow @listnrentertainment on IG  CREDITS Host: Alexis Fernandez       Executive Producer & Editor: Elise CooperDigital Producer: Zoe Panaretos DYFM Social Producer: Shania MaguaManaging Producer: Sam Cavanagh  Learn more about your ad choices. Visit megaphone.fm/adchoices

There are no comments yet.

Please log in to write the first comment.